This paper presents the pulmonary acoustic sensor telemetry array, a novel hardware prototype developed for remote pulmonary monitoring, diagnosis, and prognostication of pulmonary sounds in clinical ...

Trikafta, for cystic fibrosis, is due to be added to WHO's Essential Medicines List. But its pricing means many patients are unable to access it. Sophie Cousins reports.

A new study meticulously sampled different lung regions in people with cystic fibrosis to understand why infections persist after new treatments.

GRI-0621 appears to reduce markers of fibrosis in people with idiopathic pulmonary fibrosis, interim clinical trial data suggest.

From alveolar injury to extracellular matrix accumulation, the complex biology of pulmonary fibrosis is being unraveled alongside explorations of both Western and traditional Chinese therapies.

The study found through multi-omics integration analysis that rheumatoid arthritis is a causal factor of idiopathic pulmonary fibrosis, identifying CCL2 and CXCL2 as shared biomarkers between the ...

During my journey with idiopathic pulmonary fibrosis, I’ve noticed periods of silence that affect not only patients, but also caregivers. I experienced my first significant such period about eight ...

Vertex Pharmaceuticals beat Wall Street estimates for quarterly results on Monday, helped by demand for its new cystic fibrosis drug and product launches.

VIRGINIA BEACH, Va. (WAVY) —This weekend, there is a race for a good cause in Virginia Beach— the third annual Breathe n Run 5K, with the event supporting pulmonary fibrosis and honoring one ...

In June, Stanford Health Care announced a partnership with Kivo Health to deliver “virtual first,” “AI powered” pulmonary rehabilitation (PR) to their patients with COPD. Stanford Health ...